Quantcast

Latest Diabetes Stories

2014-05-13 23:08:12

Extend Nutrition is the most-liked diabetic snack brand by Facebook users in the USA, crossing 100,000 likes on the popular social network as of Saturday, May 10th, 2014. St. Louis, MO (PRWEB) May 13, 2014 Extend Nutrition is the most-liked diabetic food brand on Facebook, crossing 100,000 likes on the popular social network as of Saturday, May 10th, 2014. The nutrition company offers innovative snacks created by Dr. Francine Kaufman, a past president of the American Diabetes Association...

2014-05-13 23:07:54

Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking statins, a cholesterol lowering medication. Cleveland, OH (PRWEB) May 13, 2014 Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking Lipitor, a cholesterol lowering medication. Lipitor, a brand name for the drug Atorvastatin that was approved by the FDA in...

2014-05-13 23:01:37

The Firm is investigating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) May 13, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) filed on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication continue to move forward in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According...

2014-05-12 23:11:42

The Neuropathy Association and ResearchMatch research registry collaboration kicks off Neuropathy Awareness Week, which also includes Niagara Falls and other landmark lightings across the U.S. and Canada. New York, NY (PRWEB) May 12, 2014 The Neuropathy Association and ResearchMatch announce they are collaborating to launch a patient registry to improve and expedite neuropathy research. The Neuropathy Association is a national non-profit patient advocacy organization dedicated to bringing...

2014-05-12 20:23:08

Meeting supports clear path to commercialization CHARLOTTESVILLE, Va., May 12, 2014 /PRNewswire/ -- InSpark Technologies, Inc. announced today the results of a recent meeting with the FDA regarding the development and regulatory strategy for Vigilant* diabetes management software. Vigilant is an iPhone-enabled software application that analyzes blood glucose data and provides feedback about daily patterns of hyperglycemia, hypoglycemia, glucose variability, and test frequency in...

2014-05-12 11:53:53

Lunenfeld-Tanenbaum Research Institute Bioengineering a safe treatment for retinopathy, the leading cause of vision loss in Canada A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with...

2014-05-12 08:32:58

Lilly expects U.S. and European regulatory submissions by Q1 2015 INDIANAPOLIS, May 12, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of three completed Phase III clinical trials in patients with type 2 diabetes for basal insulin peglispro (BIL), which is being studied as a once-daily treatment for both type 1 and type 2 diabetes. The primary efficacy endpoint of non-inferior reduction in hemoglobin A1c (HbA1c) compared to insulin...

2014-05-12 04:21:44

WASHINGTON, May 12, 2014 /PRNewswire-iReach/ -- Women In Government will bring together legislators from across the country to participate in the Diabetes & Obesity Summit in San Diego, California on May 14-15, 2014. The Summit will afford legislators an opportunity to look at ways to identify costs and problems associated with diabetes and obesity in their states. Photo - http://photos.prnewswire.com/prnh/20140426/81072 With this conference, Women In Government will continue...

2014-05-11 23:00:24

RnRMarketResearch.com adds “Diabetic Retinopathy Global Clinical Trials Review, H1, 2014” and “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014” to its store. Dallas, Texas (PRWEB) May 11, 2014 Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014 “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014″ provides data on the Diabetic Ketoacidosis clinical trial scenario. This report provides elemental information and data relating to the clinical...

2014-05-10 23:01:30

The Firm is evaluating Lipitor lawsuits on behalf of patients whose use of the statin drug allegedly caused Type 2 diabetes. New York, New York (PRWEB) May 10, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that claim the statin drug caused patients to suffer Type 2 diabetes continue to move forward in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. Among other things, a Case Management Order issued on April 25, 2014,...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related